ARCHIVES

Groups Point to NCI Restrictions As Source Of Problems, Discuss Prioritizing Trials

This article is from The Cancer Letter archive.

Vol. 29 No. 28 | July 11, 2003

Download PDF Visit The Full Archive

Related Articles

NCI Letter to HCFA Outlines Positions, Offers Glimpse of Tactics

September 27, 1996

Firm Wins Patent For Method, Apparatus For Cryoablation.

December 15, 2000

ACCP Publishes Guidelines Recommending Low-Dose CT

May 31, 2013

RFA On Natural Inhibitors Role In Prevention Released

April 2, 1982

NCI’s Kramer Named Director, NIH Medical Applications Office.

June 16, 2000

Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease

October 25, 2013